Halozyme Therapeutics's chart data is dated 2026-10-08. Recorded technical signals: VCP. There are 20 published signal records.
Halozyme Therapeutics last closed at $109.84 (-0.86%) on 2026-10-08. Signals today: VCP. Listed on Nasdaq. Trailing 12 months PER is 32.2×. Its overall grade ranks 106 of 738 stocks in Healthcare.
About this company
Halozyme Therapeutics last closed at $109.84 (-0.86%) on 2026-10-08. Signals today: VCP. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 106/738
Valuation grade F
Related stocks
- Johnson & JohnsonCustomer
엔잘투/다잘렉스 계열 SC 제형 확대의 핵심 파트너로 연결
- Bristol Myers SquibbCustomer
SC 제형 및 항암 항체 약물의 파트너십 고객
- RocheCustomer
대형 항체 의약품의 SC 전환 파트너로 연관
ETFs holding this stock
First Trust NYSE Arca Biotechnology Index Fund · LeaderShares AlphaFactor Tactical Focused ETF · Invesco S&P MidCap 400 Pure Growth ETF
Details →About Halozyme Therapeutics
- What technical signals does Halozyme Therapeutics (HALO) have?
- Halozyme Therapeutics current technical signals: VCP.
- Is Halozyme Therapeutics a cup-and-handle pattern?
- No. Halozyme Therapeutics has no valid Cup signal right now.
- What published figures are available for Halozyme Therapeutics?
- Market cap: $12.92B. Trailing 12 months PER: 32.2×. Latest quarter PBR: 92.75×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Halozyme Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.